Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative FLOT(D) With Neoadjuvant PULSAR in Resectable Esophageal and Gastro-esophageal Junction Cancer
NCT07700420Phase 1Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in esophageal cancer and gastroesophageal junction cancer, sponsored by UT Southwestern Medical Center. Primary endpoint: Recommended Phase 2 Dose of PULSAR. Started Aug 2026; status: recruiting.
02
Conditions
esophageal cancergastroesophageal junction cancer
Beyond the preview
Go deeper on NCT07700420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700420.